...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Biogen/Eisai Scrap Aducanumab
7
Mar 21, 2019 08:32AM
2
Mar 21, 2019 03:07PM
3
Mar 21, 2019 03:37PM
5
Mar 23, 2019 03:39PM
2
Mar 24, 2019 01:45AM
3
Mar 24, 2019 01:22PM
2
Mar 24, 2019 03:35PM

"Presumably, none of the 467 patients in the BOM prespecified cognition substudy be in the placebo group for the purposes of this exercise?"

The 467 elderly patients that were 70 years old or over, including the 246 with baseline MoCA scores of 25 or below, were randomized to placebo or apabetalone.

"Would this not be a comparison from baseline to the finality to see if there would be an improvement in cognition for the sub-group by way of MoCA scores?"

Correct. Change in MoCA score from baseline will be assessed in both the placebo and apabetalone groups.

"In a sense, this is not a double-blinded cognition substudy that is being undertaken."

Incorrect. The cognition sub-study is double-blinded.

Take a look at the cognition sub-study poster from last week. 

BearDownAZ

 

2
Mar 25, 2019 10:18AM
1
Mar 25, 2019 11:45AM
2
Mar 25, 2019 12:48PM
Share
New Message
Please login to post a reply